Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy
- 24 September 2012
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 107 (4) , 388-392
Abstract
Background: Diagnosis of ductal carcinoma in situ (DCIS) by core needle biopsy showed a high rate of underestimation of invasiveness, and performing sentinel lymph node biopsy (SLNB) in DCIS patients was controversial.Methods: We analyzed 340 DCIS patients who were diagnosed by needle biopsies. Final pathology and clinicopathological features were reviewed. Predictors were accessed using the Chi‐square test and a binary logistic regression model.Results: The overall DCIS underestimation rate was 42.6%. The underestimation was significantly related to the palpability, mass or calcification by ultrasonography, grade, suspicious microinvasion, and biopsy method in univariate analysis. In multivariate analysis, palpability, ultrasonographic calcification or mass, suspicious microinvasion, and core needle biopsy were independent predictors of underestimation of invasive cancer. In cases with one or no risk predictors, the underestimation rate was 14.3%, whereas, in those with five predictors, it increased to 90.9%. Among 144 invasive cancer patients who underwent axillary staging, 15.4% had node metastasis.Conclusions: DCIS diagnosed by preoperative needle biopsy has a high probability of underestimation, and 15% of invasive cancer patients have node metastasis. SLNB may be justified in DCIS patients undergoing needle biopsies, and caution should be exercised in omitting SLNB in patients with one or no risk predictors. J. Surg. Oncol. 2013;107:388–392.Keywords
Funding Information
- Brain Korea 21 Project for Medical Science, Yonsei University
This publication has 23 references indexed in Scilit:
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008
- Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast CancerAnnals of Surgical Oncology, 2008
- Sentinel Node Biopsy Is Not a Standard Procedure in Ductal Carcinoma In Situ of the BreastAnnals of Surgery, 2008
- Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsyBritish Journal of Surgery, 2007
- Sentinel Lymph Node Biopsy for DCIS: Are We Approaching Consensus?Annals of Surgical Oncology, 2007
- Con: Sentinel Lymph Node Biopsy for DCIS. The Breast Surgeon is not a BarberAnnals of Surgical Oncology, 2006
- Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 casesBreast Cancer Research and Treatment, 2006
- American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast CancerJournal of Clinical Oncology, 2005
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerNew England Journal of Medicine, 2003
- Variation in Mammographic Breast Density by RaceAnnals of Epidemiology, 2001